PGM5
Phosphoglucomutase-like protein 5
Also known as: PGM5_HUMAN, PGMRP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15124
- Gene
- PGM5
- Ensembl
- ENSG00000154330
- Chromosome
- 9
- Canonical length
- 567 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Phosphoglucomutases (EC 5.2.2.2.), such as PGM5, are phosphotransferases involved in interconversion of glucose-1-phosphate and glucose-6-phosphate. PGM activity is essential in formation of carbohydrates from glucose-6-phosphate and in formation of glucose-6-phosphate from galactose and glycogen (Edwards et al., 1995 [PubMed 8586438]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
567 residues, UniProt reviewed canonical sequence.
>Q15124|PGM5
1 MEGSPIPVLT VPTAPYEDQR PAGGGGLRRP TGLFEGQRNY LPNFIQSVLS SIDLRDRQGC
61 TMVVGSDGRY FSRTAIEIVV QMAAANGIGR LIIGQNGILS TPAVSCIIRK IKAAGGIILT
121 ASHCPGGPGG EFGVKFNVAN GGPAPDVVSD KIYQISKTIE EYAICPDLRI DLSRLGRQEF
181 DLENKFKPFR VEIVDPVDIY LNLLRTIFDF HAIKGLLTGP SQLKIRIDAM HGVMGPYVRK
241 VLCDELGAPA NSAINCVPLE DFGGQHPDPN LTYATTLLEA MKGGEYGFGA AFDADGDRYM
301 ILGQNGFFVS PSDSLAIIAA NLSCIPYFRQ MGVRGFGRSM PTSMALDRVA KSMKVPVYET
361 PAGWRFFSNL MDSGRCNLCG EESFGTGSDH LREKDGLWAV LVWLSIIAAR KQSVEEIVRD
421 HWAKFGRHYY CRFDYEGLDP KTTYYIMRDL EALVTDKSFI GQQFAVGSHV YSVAKTDSFE
481 YVDPVDGTVT KKQGLRIIFS DASRLIFRLS SSSGVRATLR LYAESYERDP SGHDQEPQAV
541 LSPLIAIALK ISQIHERTGR RGPTVITLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PGM5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 231 nTPM
Expression across tissuesHPA
Tissue
- colon: 231 nTPM
- urinary bladder: 219 nTPM
- seminal vesicle: 202 nTPM
- prostate: 149 nTPM
- endometrium: 140 nTPM
- smooth muscle: 124 nTPM
Single-cell type
- lymphatic endothelial cells: 533 nCPM
- smooth muscle cells: 502 nCPM
- adrenal cortex cells: 340 nCPM
- microglia: 247 nCPM
- retinal bipolar cells: 244 nCPM
- myonuclei: 219 nCPM
Immune cell
- neutrophil: 4.8 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 9.2 nTPM
- medulla oblongata: 7 nTPM
- spinal cord: 6.9 nTPM
- white matter: 6.8 nTPM
- thalamus: 6.4 nTPM
- pons: 6.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.8
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- magnesium ion binding
- structural molecule activity
- intramolecular phosphotransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Alpha-D-phosphohexomutase superfamily
- Alpha-D-phosphohexomutase, alpha/beta/alpha domain I
- Alpha-D-phosphohexomutase, alpha/beta/alpha domain II
- Alpha-D-phosphohexomutase, alpha/beta/alpha domain III
- Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III
- Alpha-D-phosphohexomutase, conserved site
- Alpha-D-phosphohexomutase, C-terminal domain superfamily
- Phosphoglucomutase
- Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain I
- Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain II
- Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain III
- Phosphoglucomutase-1, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PGM5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PGM5 as an antibody target. Whether an autoantibody or antibody against PGM5 could matter depends on whether native PGM5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PGM5 is annotated at the cell surface, where native PGM5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PGM5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...